Berto P
pbe consulting, Verona, Italy.
Eur Ann Allergy Clin Immunol. 2007;39 Spec No:12-6.
Pharmacoeconomics is a relatively new discipline whose scope is to describe, measure and compare costs and outcomes of alternative healthcare programmes from a variety of perspectives. This article is aimed at describing the various types of pharmacoeconomics analyses, indicating what types of costs and outcomes could be measured within each type of study, summarising the value of modelling techniques in pharmacoeconomics studies and finally suggesting what kind of pharmacoeconomic research can usefully be conducted in order to appreciate the burden of respiratory allergic disease and to evaluate the economic impact of health technologies that can effectively be used to manage it. Pharmacoeconomics is a relatively recent discipline whose use has been spread by the necessity of decision makers in most industrialised countries, to gain understanding of the economic effect of medical technologies in parallel with their clinical performance: only a wider use of the techniques of pharmacoeconomics analysis, together with an increasing willingness of the scientific community to understand the mechanics and appreciate the added value of pharmacoeconomics analysis, can help the discipline to proceed and provide further improvement to the healthcare system and to the society.
药物经济学是一门相对较新的学科，其范围是从各种角度描述、衡量和比较替代医疗保健方案的成本和结果。本文旨在描述各种类型的药物经济学分析，指出每种研究类型中可以衡量的成本和结果类型，总结建模技术在药物经济学研究中的价值，最后提出可以开展何种有益的药物经济学研究，以认识呼吸道过敏性疾病的负担，并评估可有效用于管理该疾病的卫生技术的经济影响。药物经济学是一门相对较新的学科，大多数工业化国家的决策者由于需要在了解医疗技术临床性能的同时了解其经济效果，从而推广了该学科的应用：只有更广泛地使用药物经济学分析技术，以及科学界越来越愿意了解药物经济学分析的机制并认识其附加价值，才能帮助该学科不断发展，并为医疗保健系统和社会带来进一步改善。
